Follow
Janette Bester
Janette Bester
Senior lecturer at University of Pretoria
Verified email at up.ac.za
Title
Cited by
Cited by
Year
The dormant blood microbiome in chronic, inflammatory diseases
M Potgieter, J Bester, DB Kell, E Pretorius
FEMS microbiology reviews 39 (4), 567-591, 2015
4182015
Effects of IL-1β, IL-6 and IL-8 on erythrocytes, platelets and clot viscoelasticity
J Bester, E Pretorius
Scientific reports 6 (1), 32188, 2016
3162016
A comprehensive review on eryptosis
E Pretorius, JN du Plooy, J Bester
Cellular Physiology and Biochemistry 39 (5), 1977-2000, 2016
1962016
The inflammatory effects of TNF-α and complement component 3 on coagulation
MJ Page, J Bester, E Pretorius
Scientific reports 8 (1), 1812, 2018
1262018
Erythrocytes and their role as health indicator: Using structure in a patient-orientated precision medicine approach
E Pretorius, O Oore-ofe, S Mbotwe, J Bester
Blood reviews 30 (4), 263-274, 2016
1002016
Poorly controlled type 2 diabetes is accompanied by significant morphological and ultrastructural changes in both erythrocytes and in thrombin-generated fibrin: implications …
E Pretorius, J Bester, N Vermeulen, S Alummoottil, P Soma, AV Buys, ...
Cardiovascular diabetology 14, 1-20, 2015
932015
Acute induction of anomalous and amyloidogenic blood clotting by molecular amplification of highly substoichiometric levels of bacterial lipopolysaccharide
E Pretorius, S Mbotwe, J Bester, CJ Robinson, DB Kell
Journal of the Royal Society interface 13 (122), 20160539, 2016
872016
Viscoelastic and ultrastructural characteristics of whole blood and plasma in Alzheimer-type dementia, and the possible role of bacterial lipopolysaccharides (LPS)
J Bester, P Soma, DB Kell, E Pretorius
Oncotarget 6 (34), 35284, 2015
822015
Simultaneous presence of hypercoagulation and increased clot lysis time due to IL-1β, IL-6 and IL-8
J Bester, C Matshailwe, E Pretorius
Cytokine 110, 237-242, 2018
812018
Profound morphological changes in the erythrocytes and fibrin networks of patients with hemochromatosis or with hyperferritinemia, and their normalization by iron chelators and …
E Pretorius, J Bester, N Vermeulen, B Lipinski, GS Gericke, DB Kell
PloS one 9 (1), e85271, 2014
742014
High ferritin levels have major effects on the morphology of erythrocytes in Alzheimer's disease
J Bester, AV Buys, B Lipinski, DB Kell, E Pretorius
Frontiers in aging neuroscience 5, 88, 2013
682013
Oxidation inhibits iron-induced blood coagulation
E Pretorius, J Bester, N Vermeulen, B Lipinski
Current drug targets 14 (1), 13-19, 2013
682013
A bacterial component to Alzheimer’s-type dementia seen via a systems biology approach that links iron dysregulation and inflammagen shedding to disease
E Pretorius, J Bester, DB Kell
Journal of Alzheimer's Disease 53 (4), 1237-1256, 2016
642016
A novel method for assessing the role of iron and its functional chelation in fibrin fibril formation: the use of scanning electron microscopy
E Pretorius, N Vermeulen, J Bester, B Lipinski, DB Kell
Toxicology mechanisms and methods 23 (5), 352-359, 2013
632013
Blood clot parameters: Thromboelastography and scanning electron microscopy in research and clinical practice
E Pretorius, AC Swanepoel, S DeVilliers, J Bester
Thrombosis research 154, 59-63, 2017
462017
The potential of LPS-binding protein to reverse amyloid formation in plasma fibrin of individuals with Alzheimer-type dementia
E Pretorius, J Bester, MJ Page, DB Kell
Frontiers in aging neuroscience 10, 257, 2018
372018
Novel diagnostic and monitoring tools in stroke: an individualized patient-centered precision medicine approach
S De Villiers, A Swanepoel, J Bester, E Pretorius
Journal of atherosclerosis and thrombosis 23 (5), 493-504, 2016
362016
Interleukin‐12 and its procoagulant effect on erythrocytes, platelets and fibrin (ogen): the lesser known side of inflammation
MJ Page, J Bester, E Pretorius
British journal of haematology 180 (1), 110-117, 2018
272018
Albumin stabilizes fibrin fiber ultrastructure in low serum albumin type 2 diabetes
E Pretorius, B Lipinski, J Bester, N Vermeulen, P Soma
Ultrastructural pathology 37 (4), 254-257, 2013
272013
Viscoelasticity as a measurement of clot structure in poorly controlled type 2 diabetes patients: towards a precision and personalized medicine approach
E Pretorius, J Bester
Oncotarget 7 (32), 50895, 2016
242016
The system can't perform the operation now. Try again later.
Articles 1–20